Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great stuff SBA...Ty
Watching it close. Nice 10k trade taking out some offers a few minutes ago. Bucking the negative broad market trend is very encouraging.
Really appreciate that SBA, thank you. Great overview and indication of what the comps indicate to be potential future value of this company.
Don't know if you follow Marathon Patent Group "MARA", but you might put it on your radar. Another large Honig investment and probably the most talented and hard working CEO I've ever seen with any small company.
Expecting significant price appreciation out of it both near term and longer term. Any questions, just let me know.
Thanks again.
Peer comparisons will give you an idea where RTGN could go. (Link provided below) Nevertheless, just like weekly options, we could see heighten volatility, due in part to a national theme: #antibiotic crisis. The WORLD HEALTH ORGANIZATION came out w/ a report first of its kind sounding the alarm on antibiotics. The intentions are to raise awareness and attract investors to the industry. Similar situation to the aids epidemic. When the dots are connects, RTGN could be a direct beneficiary to a national/global #antibiotic crisis theme. We are smart money at this level.
http://ruthigen.com/wp-content/uploads/2014/04/Ruthigen_Fact_Sheet_2014April.pdf
SBA, mind if I ask you what you think is a feasible valuation for the company or your current personal price prognostication? Would value your thoughts in light of your considerable knowledge on the company.
When market connects the dots of company's value proposition and the recent W.H.O. report. Stock will go parabolic. 2.5mil float and like you said undervalued.
Nice tape action for sure. Doesn't take much to see it lift.
Good buys IMO. Low seems in
added yesterday. Here we go 6.6r/6.68r/7r could move fast. 25k on bid segmented low 6s
I'm adding a couple thousand shares here.
Not a clue, but sometimes IR plans take some time to kick in. We'll see how this pans out. I am extremely optimistic here. Was bidding 1k shares this morning -----over 30k shares is segmented 6-6.20 range on bid
Great stuff but the public needs to know. Unfortunately, the stock hasn't even traded a share today.
You have any thoughts on why the company is keeping itself such a secret? A little pro-active communication would go a long way in terms of value creation.
WORLD HEALTH ORGANIZATION: ANTIMICROBIAL RESISTANCE Global Report on surveillance April 2014. The first ever report issued exposing the antimicrobial resistance crisis on a global scale. Modern medicine was enabled due in part to antibiotics. Current antibiotics are becoming resistant to the most common bacteria--> superbugs due to the overuse/misuse of antibiotics. Already, the news is filled with stories if unbelievable infections festering in hospitals which are deadly. Biotech has seen antibiotics as a minimal way to make profit, thus antibiotics are lacking. The WHOs goal of April release of the AMR report is to enable more institutional/retail monies into the antibiotic industry and the PREVENTION SIDE.
Report:
http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1
RTGN company overview and value proposition have a strikingly similar theme of prevention in accordance to the WHO report. As the WHO drums up national/global attention, we could be a direct beneficiary of the AMR campaign, thus many eyes watching this stock.
NY TIMES May 10, 2014 SUNDAY Edition: "The Rise of Antibiotic Resistance"
http://www.nytimes.com/2014/05/11/opinion/sunday/the-rise-of-antibiotic-resistance.html?smid=tw-share&smv1&_r=0
24k flashed on bid. May see some buying here today
Great stuff SBA, thank you. Catching a little early buy interest this am.
The theme is fresh and with the recent addition of an IR team. I wouldn't be surprised this company gets national attention in the near term, as the silent period appears to be expired.
It's incredible stuff. You would think the company itself would be sounding the bell and highlighting some of what you have so well presented.
Highly compelling stuff, the company should be leveraging the hell out of it on their own behalf.
Lots of value here, just currently a limited audience.
The antibiotics resistance theme which is debuting on the national press is the attention this stock needs. The World Health Organization, along with ROCHE are sounding the alarm. If I was mgmt here with the silent period over. I would piggy back the movement. Interesting how the IPO of the stock falls right in line to the theme. This stock could take over when investors draw the dots.
The amount of articles that are out in the past 2 days are staggering.
http://www.nytimes.com/2014/05/08/science/antibiotic-resistant-germs-lying-in-wait.html
http://www.who.int/mediacentre/news/releases/2014/amr-report/en/
http://www.economist.com/news/international/21601547-running-out-ammunition-war-germs-drugs-dont-work
http://www.latimes.com/science/sciencenow/la-sci-sn-antibiotic-drug-resistance-who-warning-20140502-story.html
Question is what is it going to take for investors to take notice? Trades very thin. A little buy interest would go a long way for sure. Very undervalued imo.
"Underwriters have purchased an additional 154,290 shares from Ruthigen pursuant to the option".
Today, underwriters purchased $1.16 MILLION worth of stock at 7.25 a share, which is a .75 premium to current price per share.
"WHO sounds alarm on widespread 'superbug' infections" will soon create a lot of attention for the industry.
http://www.usatoday.com/story/news/nation/2014/04/30/who-alarm-superbug-infections/8502853/
The superbug, MRSA, & MERS topic is starting to get national attention.
The exposure will come recent developments in the news. Super-bugs, MRSA, and MERS are starting to get attention. We are well positioned here to ride this next trend.
Agree, it's not a lack of value but rather a lack of exposure.
Undoubtedly the more investors are educated about the company, the more shareholder value that will ultimately be created.
I would expect an IR plan to kick in to get this moving. Not many shares out there. Speculation of Dr.Frost owning a bunch of stock overtime could draw his investor base into the stock.
Yeah a little disappointed as well by the lack of interest today. Surely that should change in time.
Not the volume I was expecting, but the silent period is over after it became a new issue. Wouldn't be surprised of a pipeline of news to follow.
Excellent news! Let's see how she acts today.
Yes, I've noticed Dr. Frost and Mr. Honig tend to dual invest. If what you heard is true about Dr. Frost owning a sizable position, he must file +5%. The filing alone could trigger a buying pressure due to Dr. Frost's following is extensive in the investing community.
Absolutely SBA. I am invested in another company with Mr. Honig. I've found the man to be very smart and involved only if he see's tremendous value in the company. Appears he's made a sizeable investment in this one.
I have also heard that Dr. Phil frost may have a sizeable investment here although I can not substantiate it. Dr. Frost is another highly accomplished investor as you may know.
Jim Schutz & Barry Honig recent SG13(s) are very interesting.
Thanks for the reply SBA. I'm expecting the IND filing anytime as well. Thanks for the clarity on the cash. Sure appears as though the stock is very undervalued to say the least.
I like some of the larger investors names. I've personally seen them make some very profitable investments over time. I'd expect this one would likely be no different.
IPO Offering 2.2million shares x 7.25 = $16 Million cash. Then in the S1 filing an IND filing is any day which this extremely low float stock could move quick.
Took a position yesterday SBA. Can you confirm this company has $18M in cash? with it's tiny market cap, over half the value appears to be in cash. Assuming so, that is insane and would render the stock seemingly incredibly undervalued.
Only 2.2 million shares this will erupt!
High Abnormal volume today. Someone buying bc IND catalyst coming! Read S1
Silent period after IPO cooling off. S1 states IND Filing in April. Few days left to play cataylst.
Review IBB/IPO etf SPEC money flowing back in at the same time an IND filing is possible according to S1. This is a low float 2.2million in the IPO the rest of the stock from private placement is restricted. The recent SG-13(S) have taken a % out of the 2.2million in the IPO, which means there aren't many shares out there.
easy play here on a IND filing, then another catalyst 30 days for FDA response.
Hummm could be worth some $$$$
Tiny float less than 8 trading days for IND!
Followers
|
8
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
107
|
Created
|
03/28/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |